Medicare price talks defended by DoJ as Trump pledges to lower drug prices

Responding to a lawsuit by Novartis (NVS), the U.S. Department of Justice has defended Medicare price negotiations, signaling that the controversial program introduced by former President Biden will continue under President Trump’s new administration.

Meanwhile, Trump himself expressed concerns over soaring